Additional information
| Active substance | Dabigatran |
|---|---|
| Water Retention | No significant water retention |
| Hepatotoxicity | No significant hepatotoxicity |
| Lab Test | Monitoring of renal function and possibly coagulation parameters |
| Also known as | Dabigatran |
| WAREHOUSE | International Warehouse 2 |
| Blood pressure | Typically does not affect blood pressure |
| Trade name | Pradaxa |
| Storage conditions | Store at room temperature away from moisture and heat |
| Chemical name | N-{2-[4-(N'-{[(Hexyloxy)carbonyl]carbamimidoyl}carbamimidoyl)phenylaminomethyl]-1-methyl-1H-benzimidazol-5-ylcarbonyl}-N-pyridin-2-yl-beta-alanine ethyl ester |
| Formula | C34H41N7O5 |
| Substance class | Direct thrombin inhibitor |
| Main action | Anticoagulant |
| Half-life | 12 to 17 hours |
| Dosage (medical) | 150 mg or 110 mg twice daily depending on renal function |
| Dosage (sports) | Not applicable as it is not used for sports enhancement |
| Effects | Reduces the risk of stroke and systemic embolism in patients with non-valvular atrial fibrillation |
| Side effects | Bleeding, gastrointestinal upset, heartburn, nausea |
| Use in sports | None, as it does not enhance athletic performance |
| Manufacturer | Boehringer |
Champix 56 tabs Pfizer
Januvia 100mg Merckgroup
LGD-4033 10mg Pro Nutrition
Fostimon (Merional) 150 IU HMG IBSA
Zimaks 400 Bilim
AVELOX 400 Bayer
Fostimon (Merional) 75 (HMG) IBSA
Avory Pharma Dianabol 10mg 100 Kapsel
Norvacs 10 mg Pfizer 

Reviews
There are no reviews yet.